1. EP-1534 Clinical Outcomes for Patients with Gleason Score 10 Prostate Adenocarcinoma: TROD 09-004 Study. (April 2019) Authors: Ozyigit, G.; Onal, H.C.; Hurmuz, P.; Iribas, A.; Cetin, I.; Gorken, I.B.; Yalman, D.; Akyol, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-0734: The effect of TAB duration and pelvic RT in prostate cancers with gleason score 8-10: TROG study. (May 2017) Authors: Ozyigit, G.; Onal, C.; Igdem, S.; Arican Alicikus, Z.; Iribas, A.; Akin, M.; Yalman, D.; Cetin, I.; Aksu, M.G.; Atalar, B.; Dincbas, F.; Aydin, B.; Sert, F.; Yildirim, C.; Gorken, I.B.; Agaoglu, F.Y.; Korcum, A.F.; Ozkok, S.; Darendeliler, E.; Akyol, F. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-0750: Conventionally-fractionated VMAT vs. SBRT in prostate cancer:PSA kinetics, toxicity, quality of life. (April 2016) Authors: Tambas, M.; Agaoglu, F.; Iribas, A.; Guveli, M.; Dizdar, Y.; Okutan, M.; Ozkan, D.; Tenekeci, N.; Darendeliler, E. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗